Free Trial

Cerity Partners LLC Purchases 216,034 Shares of Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Cerity Partners LLC lifted its position in Exelon Co. (NASDAQ:EXC - Free Report) by 168.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 343,950 shares of the company's stock after acquiring an additional 216,034 shares during the period. Cerity Partners LLC's holdings in Exelon were worth $13,947,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BOKF NA grew its holdings in shares of Exelon by 7.6% during the first quarter. BOKF NA now owns 17,722 shares of the company's stock valued at $660,000 after buying an additional 1,257 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Exelon by 1.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,390,685 shares of the company's stock valued at $52,249,000 after purchasing an additional 16,661 shares during the period. SVB Wealth LLC grew its holdings in shares of Exelon by 6.5% during the 1st quarter. SVB Wealth LLC now owns 12,542 shares of the company's stock worth $471,000 after purchasing an additional 769 shares in the last quarter. B. Riley Wealth Advisors Inc. lifted its position in Exelon by 10.3% in the first quarter. B. Riley Wealth Advisors Inc. now owns 22,248 shares of the company's stock worth $841,000 after purchasing an additional 2,075 shares during the period. Finally, Tidal Investments LLC increased its stake in shares of Exelon by 97.1% in the first quarter. Tidal Investments LLC now owns 69,268 shares of the company's stock valued at $2,602,000 after buying an additional 34,132 shares in the last quarter. Institutional investors and hedge funds own 80.92% of the company's stock.

Exelon Trading Up 0.8 %

Shares of EXC stock traded up $0.32 during trading hours on Tuesday, hitting $39.45. 1,537,959 shares of the company's stock traded hands, compared to its average volume of 6,719,977. The company has a quick ratio of 0.97, a current ratio of 1.09 and a debt-to-equity ratio of 1.66. Exelon Co. has a 12 month low of $33.35 and a 12 month high of $41.42. The stock has a market cap of $39.64 billion, a PE ratio of 16.10, a price-to-earnings-growth ratio of 2.76 and a beta of 0.54. The stock's 50 day simple moving average is $39.61 and its 200 day simple moving average is $37.84.

Exelon (NASDAQ:EXC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.04. Exelon had a return on equity of 9.47% and a net margin of 10.60%. The company had revenue of $6.15 billion for the quarter, compared to analysts' expectations of $5.85 billion. During the same period last year, the business earned $0.67 EPS. Exelon's quarterly revenue was up 2.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Exelon Co. will post 2.46 EPS for the current year.

Exelon Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Monday, November 11th will be given a dividend of $0.38 per share. The ex-dividend date is Friday, November 8th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 3.85%. Exelon's dividend payout ratio is presently 62.55%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on EXC shares. Wells Fargo & Company lifted their price objective on shares of Exelon from $40.00 to $42.00 and gave the stock an "equal weight" rating in a research note on Friday, August 2nd. Morgan Stanley reduced their price objective on Exelon from $46.00 to $44.00 and set an "equal weight" rating for the company in a report on Friday. Scotiabank lifted their price target on Exelon from $37.00 to $40.00 and gave the stock a "sector perform" rating in a report on Tuesday, August 20th. UBS Group upped their price objective on Exelon from $40.00 to $43.00 and gave the company a "neutral" rating in a report on Friday, September 20th. Finally, Jefferies Financial Group began coverage on shares of Exelon in a research report on Thursday, September 19th. They issued a "buy" rating and a $46.00 target price for the company. Eleven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Exelon currently has a consensus rating of "Hold" and an average target price of $41.25.

Check Out Our Latest Analysis on EXC

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Articles

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should you invest $1,000 in Exelon right now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines